24/7 Patient Assistance: 760-405-8205

Patients who underwent treatment with Necitumumab had a better median overall survival (11.5 months) than those who were treated with gemcitabine and cisplatin (9.9 months).

U N C O M M O N   side effects

Necitumumab

(Lung Cancer)

Necitumumab is injected intravenously over the course of 60 minutes.

C O M M O N   side effects